Ondansetron HCL 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FNJPA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,285
Award facts
- Contract value 100% obligated
- $2,284.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,284.77 to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competition and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a commonly used antiemetic medication primarily employed to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery in military and federal healthcare settings.
This delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and prime vendor to federal medical supply chains, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support Defense Health Agency operations, military healthcare systems, and other government healthcare entities worldwide. The company's extensive portfolio of competitively awarded federal contracts demonstrates its established capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FNJPA?
SPE2DB25FNJPA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FNJPA worth?
The government has obligated $2,285 on SPE2DB25FNJPA.
Is contract SPE2DB25FNJPA an order under another contract?
Yes. SPE2DB25FNJPA is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNJPA competed?
The extent of competition for SPE2DB25FNJPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award